Various studies used the CCL4‐based mouse models to evaluate potential therapeutic interventions, but they differ in the dose, frequency and duration of CCL4 administration, leading to differences in illness between studies and sometimes opposing results.33 In the present study, we established, described and compared chronic CCL4‐induced mouse models for liver fibrosis and cirrhosis in detail. Here, CCL4 is linked to Hepatic fibrosis.